Pradaxa Lawsuit Filed Against Boehringer Ingelheim
Yet another man has come forward with claims that Boehringer Ingelheim Pharmaceuticals hid the dangers of its anticoagulant drug Pradaxa and caused death and injury to thousands so they could generate massive sales.
According to Courthouse News, Arthur Gabriel was prescribed Pradaxa in 2011 to help thin his blood and reduce the risk of stroke. However, after taking the drug for six months Gabriel suffered a number of serious health issues and was hospitalized for a severe hematoma. He required surgery and a blood transfusion in order to correct the problem.
In his Pradaxa lawsuit that was recently filed, Gabriel claims that Boehringer failed to tell the public that "there is no agent to reverse the anticoagulation effects of Pradaxa and that if serious bleeding occurs, it may be irreversible, permanently disabling, and life-threatening."
Furthermore, he alleges that Boehringer did not include a proper boxed or a bolded warning about the risk of serious bleeding side-effects.
Other blood thinning medications have traditionally been made so certain agents could stimulate coagulation before any serious bleeding events could occur.
He is seeking punitive damages for negligence, strict liability, negligence misrepresentation, breach of warranty, and fraudulent concealment.
If you or a loved one has been hurt or sickened by a dangerous drug such as Pradaxa, there may be legal options at your disposal. Call Sokolove Law today to learn more about possibly pursuing a Pradaxa lawsuit. For legal help, call (800) 581-6358.